Biotech Industry Complains of Patent Bottleneck in Taiwan

Law360, New York (October 12, 2003, 12:00 AM EDT) -- Taiwanese biotech patents are bottlenecked at the Intellectual Property Office (IPO) due to the lack of examiners to cope with the workload, experts at an industry conference complained Thursday, according to the Taipei Times.

Taiwan currently has 150 patent examiners, but the vast majority work on information technology innovations. Only 20 examiners are dedicated to biotechnology and medicine. Another 50 examiners are being recruited this year, but only two will be assigned to biotech, the newspaper reported, citing government sources.

The IPO outsources some of the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.